Solventum Co. (NYSE:SOLV) Stock Holdings Lowered by Prudential PLC

Prudential PLC cut its position in shares of Solventum Co. (NYSE:SOLV - Free Report) by 33.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,090 shares of the company's stock after selling 15,461 shares during the quarter. Prudential PLC's holdings in Solventum were worth $1,988,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in SOLV. Modus Advisors LLC acquired a new stake in shares of Solventum during the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC acquired a new stake in Solventum in the fourth quarter worth $26,000. Crews Bank & Trust acquired a new stake in Solventum in the fourth quarter worth $32,000. Synergy Asset Management LLC bought a new stake in Solventum in the fourth quarter valued at $35,000. Finally, Spire Wealth Management acquired a new position in shares of Solventum during the fourth quarter valued at $37,000.

Analyst Ratings Changes

A number of research firms recently weighed in on SOLV. Piper Sandler increased their price objective on shares of Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a report on Friday, February 28th. Wells Fargo & Company lifted their price target on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday, February 28th. Mizuho increased their price objective on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. The Goldman Sachs Group raised their target price on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research report on Monday, March 3rd. Finally, Bank of America boosted their price target on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Solventum presently has an average rating of "Hold" and an average price target of $79.86.

Solventum Price Performance

NYSE SOLV traded down $0.57 on Friday, reaching $64.61. 314,172 shares of the stock traded hands, compared to its average volume of 1,342,760. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The firm's fifty day simple moving average is $74.36 and its 200 day simple moving average is $71.72. The company has a market cap of $11.18 billion and a price-to-earnings ratio of 23.49.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.